Evidence map›Paper›PMID 27245298›Full record

ArticleEuropean journal of human genetics : EJHG2016

Identification of partial SLC20A2 deletions in primary brain calcification using whole-exome sequencing.

Stéphanie David, Joana Ferreira, Olivier Quenez, Anne Rovelet-Lecrux, Anne-Claire Richard, Marc Vérin, Snejana Jurici, Isabelle Le Ber, Anne Boland, Jean-François Deleuze and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in European journal of human genetics : EJHG, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Brain Calcifications: Genetic, Molecular, and Clinical Aspects.International journal of molecular sciences · 2023
    Review
  4. PDGF receptor mutations in human diseases.Cellular and molecular life sciences : CMLS · 2021
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 7 institutions in 2 countries.

Stéphanie DavidInserm U1079, Rouen University, IRIB, Normandy University, Rouen, France.
Joana FerreiraInserm U1079, Rouen University, IRIB, Normandy University, Rouen, France.
Olivier QuenezInserm U1079, Rouen University, IRIB, Normandy University, Rouen, France.
Anne Rovelet-LecruxInserm U1079, Rouen University, IRIB, Normandy University, Rouen, France.
Anne-Claire RichardNormandy Centre for Genomic Medicine and Personalized Medicine, Rouen, France.
Marc VérinDepartment of Neurology, Pontchaillou Hospital, Rennes University Hospital, Rennes, France.
Snejana JuriciDepartment of Neurology, Perpignan Hospital, Perpignan, France.
Isabelle Le BerSorbonne Universités, UPMC Univ Paris 06, Inserm UMRS1127, CNRS UMR 7225, ICM, Paris, France.
Anne BolandCentre National de Génotypage, Institut de Génomique, CEA, Evry, France.
Jean-François DeleuzeCentre National de Génotypage, Institut de Génomique, CEA, Evry, France.
Thierry FrebourgInserm U1079, Rouen University, IRIB, Normandy University, Rouen, France.
João Ricardo Mendes de OliveiraKeizo Asami Laboratory, Federal University of Pernambuco, Recife, Brazil.
Didier HannequinInserm U1079, Rouen University, IRIB, Normandy University, Rouen, France.
Dominique CampionInserm U1079, Rouen University, IRIB, Normandy University, Rouen, France.
Gaël NicolasInserm U1079, Rouen University, IRIB, Normandy University, Rouen, France.
Université de Rouen Normandie · FRInserm · FRCommissariat à l'Énergie Atomique et aux Énergies Alternatives · FRCentre Hospitalier de Perpignan · FRCentre Hospitalier du Rouvray · FRHôpital Pontchaillou · FRUniversidade Federal de Pernambuco · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Primary brain calcification (PBC) is a dominantly inherited calcifying disorder of the brain. SLC20A2 loss-of-function variants account for the majority of families. Only one genomic deletion encompassing SLC20A2 and six other genes has been reported. We performed whole-exome sequencing (WES) in 24 unrelated French patients with PBC, negatively screened for sequence variant in the known genes SLC20A2, PDGFB, PDGFRB and XPR1. We used the CANOES tool to detect copy number variations (CNVs). We detected two deletions of exon 2 of SLC20A2 in two unrelated patients, which segregated with PBC in one family. We then reanalyzed the same series using a QMPSF assay including one amplicon in each exon of SLC20A2 and detected two supplemental partial deletions in two patients: one deletion of exon 4 and one deletion of exons 4 and 5. These deletions were missed by the first screening step of CANOES but could finally be detected after readjustment of bioinformatic parameters and use of a genotyping step of CANOES. This study reports the first partial deletions of SLC20A2 and strengthens its position as the major PBC-causative gene. It is possible to detect short CNVs from WES data, although the sensitivity of such tools should be evaluated in comparison with other methods.

Indexed as

ExomeGene DeletionAgedAlgorithmsBrain DiseasesCalcinosisFemaleHumansMaleMiddle AgedSequence Analysis, DNASodium-Phosphate Cotransporter Proteins, Type IIISyndromeXenotropic and Polytropic Retrovirus ReceptorSLC20A2 protein, humanSodium-Phosphate Cotransporter Proteins, Type IIIXenotropic and Polytropic Retrovirus ReceptorXPR1 protein, human

Identifiers

PMID27245298
PMCPMC5110050
OpenAlexW2460239828

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.